BIOMAT Database Logo BIOMAT Database Logo

[Hypocalcemia of hypomagnesemia: parathyroid deficiency rather tha parathyroid resistance]. 2000

V Vlaeminck-Guillem, and J L Wémeau

UI MeSH Term Description Entries
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D008275 Magnesium Deficiency A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936) Deficiency, Magnesium,Deficiencies, Magnesium,Magnesium Deficiencies
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011547 Pseudohypoparathyroidism A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN. Albright Hereditary Osteodystrophy,PHPIa,Albright Hereditary Osteodystrophy with Multiple Hormone Resistance,PHD Ib,PHD1b,PHP Ia,Pseudohypoparathyroidism Type 1B,Pseudohypoparathyroidism, Type Ia,Pseudohypoparathyroidism, Type Ib,Hereditary Osteodystrophy, Albright,Osteodystrophy, Albright Hereditary,Pseudohypoparathyroidism Type 1Bs,Pseudohypoparathyroidisms,Pseudohypoparathyroidisms, Type Ia,Pseudohypoparathyroidisms, Type Ib,Type Ia Pseudohypoparathyroidism,Type Ia Pseudohypoparathyroidisms,Type Ib Pseudohypoparathyroidism,Type Ib Pseudohypoparathyroidisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Vlaeminck-Guillem, and J L Wémeau
Hypocalcemia from deficiency of and resistance to parathyroid hormone.
January 1985, Advances in pediatrics,
V Vlaeminck-Guillem, and J L Wémeau
Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness.
June 1969, The Journal of clinical endocrinology and metabolism,
V Vlaeminck-Guillem, and J L Wémeau
[Hypocalcemia induced by cisplatin. Inappropriate parathyroid response due to hypomagnesemia].
January 1991, Presse medicale (Paris, France : 1983),
V Vlaeminck-Guillem, and J L Wémeau
Hypocalcemia and hypomagnesemia.
May 1998, The Veterinary clinics of North America. Small animal practice,
V Vlaeminck-Guillem, and J L Wémeau
[Hypomagnesemia-induced hypocalcemia: functional hypoparathyroidism, parathyroid hormone- and vitamin D-resistant].
July 1990, Klinische Wochenschrift,
V Vlaeminck-Guillem, and J L Wémeau
Primary hypomagnesemia with secondary hypocalcemia, diarrhea and insensitivity to parathyroid hormone.
July 1972, The American journal of digestive diseases,
V Vlaeminck-Guillem, and J L Wémeau
Transient neonatal hypocalcemia, hypomagnesemia, and high serum parathyroid hormone with maternal hyperparathyroidism.
May 1975, Annals of internal medicine,
V Vlaeminck-Guillem, and J L Wémeau
Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
January 1973, The Journal of clinical investigation,
V Vlaeminck-Guillem, and J L Wémeau
Cisplatin-induced hypocalcemia and hypomagnesemia.
November 1980, Archives of internal medicine,
V Vlaeminck-Guillem, and J L Wémeau
Woman with hypomagnesemia and hypocalcemia.
May 2015, Clinical chemistry,
Copied contents to your clipboard!